# A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)

> **NCT00565292** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 50 (actual)

## Conditions studied

- Hypercholesterolemia
- Hyperlipidemia

## Interventions

- **DRUG:** MK0859

## Key facts

- **NCT ID:** NCT00565292
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00565292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00565292, "A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00565292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*